Capital International LTD Biogen Inc. Transaction History

Capital International LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $1.82 Million - $2.3 Million	-6,757 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$220.06 - $304.07 $955,060 - $1.32 Million	-4,340 Reduced 39.11%	6,757 $2.01 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $1.08 Million - $1.21 Million	4,944 Added 80.35%	11,097 $2.58 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $366,872 - $404,397	-1,673 Reduced 21.38%	6,153 $1.44 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $255,067 - $398,955	1,177 Added 17.7%	7,826 $1.85 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $324,452 - $410,953	1,165 Added 21.24%	6,649 $2 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $899,314 - $1.18 Million	3,064 Added 126.61%	5,484 $1.94 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $623,198 - $742,722	2,420 New	2,420 $702,000

1,049

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

Stay updated on Capital International LTD with notifications on news.